Extrait

To assess the immune response to the study vaccine in terms of seroprotection status for diphtheria, tetanus, Hib and poliovirus types 1, 2 and 3 antigens, and in terms of sero-positivity to the pertussis antigens, one month after the third dose of primary vaccination

Critère d'inclusion

• Healthy volunteers (immunisation against diphtheria-tetanus-acellular pertussis-inactivated poliovirus and Haemophilus influenzae type b)

Liens

• euctr